A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

December 6, 2016

Primary Completion Date

August 7, 2018

Study Completion Date

July 23, 2019

Conditions
Sjogrens Disease
Interventions
BIOLOGICAL

Abatacept

OTHER

Placebo

Trial Locations (71)

1015

Organizacion Medica De Investigacion S.A. (Omi), Capital Federal

1111

Consultorios Medicos Dr. Catalan Pellet, CABA

1428

Local Institution, Buenos Aires

1431

Local Institution, Ciudad Autonoma Beunos Aires

1646

Instituto de Asistencia Reumatologica Integral, San Fernando

3124

Local Institution, Camberwell

4558

Local Institution, Maroochydore

5000

Instituto Reumatologico Strusberg, Córdoba

5011

Local Institution, Woodville

6009

Local Institution, Nedlands

11021

Northwell Health, Great Neck

13003

Hopital Europeen, Marseille

13008

Local Institution, Marseille

14080

Local Institution, Distrito Federal

15213

University of Pittsburgh Medical Center, Pittsburgh

18015

East Penn Rheumatology, Bethlehem

20122

Local Institution, Milan

21224

Johns Hopkins University, Baltimore

27710

Duke Clinical Research Unit, Duke Univ Med Ctr, Duke South, Durham

28203

Local Institution, Charlotte

28204

Joint and Muscle Medical Care and Research Institute (JMMCRI), Charlotte

30046

North Georgia Rheumatology Group, Lawrenceville

30625

Med Hochschule Hannover, Hanover

33075

Local Institution, Bordeaux

33100

Ospedale Santa Maria Della Misericordia, Udine

34295

Hopital Lapeyronie, Montpellier

37000

Consultorio Medico de Reumatologia Dr.Jesus Alberto Lopez Garcia, León

38305

West Tennessee Research Institute, Jackson

42105

Krankenhaus St. Josef, Wuppertal

42472

Local Institution, Daegu

55121

St. Paul Rheumatology, P.A., Eagan

61469

Local Institution, Gwangju

64460

Hospital Universitario Dr. Jose Eleuterio Gonzalez, Monterrey

67098

Local Institution, Strasbourg

73103

Health Research Of Oklahoma, Oklahoma City

75231

Metroplex Clinical Research Center, Dallas

Scott Zashin Inc., Dallas

75475

Local Institution, Paris

78213

Centro de Alta Especialidad en Reumatologia e Investigacion del Potosi S.C., San Luis Potosí City

79106

Medizinische Universitaetsklinik Freiburg, Freiburg im Breisgau

80228

Colorado Arthritis Associates, Lakewood

83702

Intermountain Research Center Inc., Boise

92506

Riverside Medical Clinic, Riverside

92835

St. Jude Hospital Yorba Linda, Fullerton

94275

Local Institution, Le Kremlin-Bicêtre

1048560

Local Institution, Chuo-ku

1538515

Local Institution, Meguro-ku

1608582

Local Institution, Shinjuku-Ku

1738610

Local Institution, Itabashi-ku

3050005

Local Institution, Tsukuba

4313192

Local Institution, Hamamatsu

4578511

Local Institution, Nagoya

6638501

Local Institution, Nishinomiya-shi

7108522

Local Institution, Kurashiki-shi

8078555

Local Institution, Kitakyushu-shi

8528501

Local Institution, Nagasaki

9808574

Local Institution, Sendai

01605

Clinical Pharmacology Study Group, Worcester

16635-8406

Altoona Center For Clinical Research, Duncansville

29055-450

Local Institution, Vitória

40150-150

Local Institution, Savaldor

90480-000

Local Institution, Porto Alegre

04032-060

Local Institution, São Paulo

638 00

Revmatologie s.r.o., Brno

0608648

Local Institution, Sapporo

602-8566

Local Institution, Kamigyō-ku

00909

Local Institution, San Juan

00918

Local Institution, San Juan

06591

Local Institution, Seoul

171 64

Local Institution, Solna

751 85

Local Institution, Uppsala

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT02915159 - A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome | Biotech Hunter | Biotech Hunter